TELA Bio Inc
NASDAQ:TELA

Watchlist Manager
TELA Bio Inc Logo
TELA Bio Inc
NASDAQ:TELA
Watchlist
Price: 0.97 USD 0.41% Market Closed
Market Cap: $42.5m

Operating Margin

-46%
Current
Improving
by 24.4%
vs 3-y average of -70.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-46%
=
Operating Income
$-35.5m
/
Revenue
$77.1m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-46%
=
Operating Income
$-35.5m
/
Revenue
$77.1m

Peer Comparison

Country Company Market Cap Operating
Margin
US
TELA Bio Inc
NASDAQ:TELA
39m USD
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.8B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
36.4B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
120.8B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
12.1B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 81% of companies in the United States of America
Percentile
19th
Based on 14 112 companies
19th percentile
-46%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

TELA Bio Inc
Glance View

Market Cap
42.5m USD
Industry
Health Care

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company is headquartered in Malvern, Pennsylvania and currently employs 123 full-time employees. The company went IPO on 2019-11-08. The firm is focused on designing, developing and marketing tissue reinforcement materials for soft tissue reconstruction. The company offers a portfolio of products and solutions for care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. Its portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), is used for ventral hernia repair and abdominal wall reconstruction, inguinal hernia repair and hiatal hernia repair. Its OviTex PRS Reinforced Tissue Matrix (OviTex PRS) addresses needs in plastic and reconstructive surgery. Its OviTex PRS product is designed for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft tissue repair or reinforcement in plastic and reconstructive surgery. Its subsidiary include TELA Bio Limited.

TELA Intrinsic Value
3.62 USD
Undervaluation 73%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-46%
=
Operating Income
$-35.5m
/
Revenue
$77.1m
What is TELA Bio Inc's current Operating Margin?

The current Operating Margin for TELA Bio Inc is -46%, which is above its 3-year median of -70.4%.

How has Operating Margin changed over time?

Over the last 3 years, TELA Bio Inc’s Operating Margin has increased from -97.5% to -46%. During this period, it reached a low of -97.5% on Sep 30, 2022 and a high of -46% on Sep 30, 2025.

Back to Top